ArticlebioRxiv : the preprint server for biology2026
Learning molecular determinants of selective small-molecule partitioning across biomolecular condensates.
Article in bioRxiv : the preprint server for biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
The functional role of biomolecular condensates is shaped by the composition of constituent proteins, nucleic acids, ions, and small molecules. Selective partitioning of small molecules into condensates has therefore emerged as a potential route to condensate-specific chemical probes and therapeutics. Although partitioning is influenced by differences in solvation environments between coexisting dense and dilute phases, a molecular framework connecting small-molecule structure to condensate-specific enrichment remains lacking. Here, we use existing experimental partitioning data for a library of FDA-approved drugs and metabolites across four biomolecular condensates to develop an interpretable graph-based model of small-molecule partitioning. By combining multitask pretraining, condensate-specific fine-tuning, evidential uncertainty quantification, and atom-level attribution analysis, our model predicts continuous partition coefficients with improved accuracy over descriptor-based approaches. Atom-level attributions reveal that condensate partitioning is not governed by a universal chemical rule: the same molecular scaffold can be read differently by distinct condensate environments, with local atomic context and connectivity determining whether specific atoms promote or suppress enrichment. We further apply the trained model to ~1.7 million drug-like molecules from ChEMBL, identifying a chemically diverse space of predicted condensate-selective partitioners and mapping regions where predictions are confident versus where new measurements would be most informative. Together, this work establishes condensate partitioning as a chemically learnable property shaped by the interplay between small-molecule structure and condensate-specific microenvironments, providing an interpretable and uncertainty-aware framework for defining molecular determinants of partitioning and guiding the discovery of condensate-selective small molecules.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.